14.1 Carbohydrate Catabolism and Anabolism: Glycolysis, Gluconeogenesis, Glycogen, and Pentose Phosphate Pathway

14.1 Carbohydrate Catabolism and Anabolism: Glycolysis, Gluconeogenesis, Glycogen, and Pentose Phosphate Pathway

Quick Answer: Carbohydrate metabolism maintains cellular ATP levels and biosynthetic precursors through tightly coupled, reciprocally regulated pathways. Glycolysis breaks down glucose into two molecules of pyruvate, generating a net yield of $2\text{ ATP}$ and $2\text{ NADH}$. It is controlled at three physiologically irreversible steps: hexokinase, phosphofructokinase-1 (PFK-1), and pyruvate kinase. Under anaerobic conditions, lactate dehydrogenase regenerates $\text{NAD}^+$ to keep glycolysis running. Gluconeogenesis synthesizes glucose from non-carbohydrate precursors (pyruvate, lactate, glycerol, glucogenic amino acids) by bypassing the three irreversible glycolytic steps at the cost of $4\text{ ATP}$, $2\text{ GTP}$, and $2\text{ NADH}$ per glucose molecule. The bifunctional enzyme PFK-2/FBPase-2 serves as the metabolic switch: glucagon promotes PKA phosphorylation, lowering fructose-2,6-bisphosphate (F-2,6-BP) and activating gluconeogenesis, whereas insulin elevates F-2,6-BP to drive glycolysis. Glycogen phosphorylase uses phosphorolysis to release glucose-1-phosphate from glycogen, conserving energy, while the pentose phosphate pathway (PPP) produces $\text{NADPH}$ for reductive biosynthesis and protects erythrocytes against oxidative stress via reduced glutathione.

---

The Glycolytic Pathway (Embden-Meyerhof-Parnas Pathway)

Glycolysis is a ubiquitous cytosolic catabolic sequence that converts one molecule of $\text{D-glucose}$ ($6\text{C}$) into two molecules of pyruvate ($3\text{C}$). The pathway comprises ten discrete enzyme-catalyzed reactions divided into two distinct metabolic phases:

1. The Preparatory (Investment) Phase (Steps 1–5): Two molecules of ATP are consumed to phosphorylate hexose intermediates and cleave them into two interconvertible triose phosphate molecules.
2. The Payoff Phase (Steps 6–10): The two triose molecules are oxidized and converted to pyruvate, yielding four molecules of ATP and two molecules of $\text{NADH}$.

Overall Stoichiometry and Free Energy Change

The net chemical equation of glycolysis under aerobic conditions is:

$\text{Glucose} + 2\text{NAD}^+ + 2\text{ADP} + 2\text{P}_i \longrightarrow 2\text{Pyruvate} + 2\text{NADH} + 2\text{H}^+ + 2\text{ATP} + 2\text{H}_2\text{O}$

Under standard biochemical conditions ($\text{pH } 7.0$, $25^\circ\text{C}$, $1\text{ M}$ reactants, $1\text{ mM } \text{Mg}^{2+}$):

$\Delta G^{\circ\prime} = -85\text{ kJ/mol}$

Under intracellular physiological conditions in human erythrocytes or hepatocytes, where reactant and product concentrations are far from $1\text{ M}$, the actual free energy change is even more exergonic:

$\Delta G_{\text{phys}} \approx -73\text{ to } -80\text{ kJ/mol}$

---

Step-by-Step Enzymatic Reactions of Glycolysis

Mechanistic Highlights of Key Steps

Step 1: Hexokinase vs. Glucokinase (Hexokinase IV)

The phosphorylation of neutral D-glucose to negatively charged glucose-6-phosphate (G6P) creates a charged phosphate ester that cannot cross the hydrophobic lipid bilayer via glucose transporters (GLUT family), effectively trapping the hexose inside the cell.

• Hexokinase (Isozymes I–III): Found in muscle and most non-hepatic tissues. Possesses a very low Michaelis constant ($K_m \approx 0.1\text{ mM}$), operating near saturation ($V_{\max}$) under normal fasting blood glucose concentrations ($4-5\text{ mM}$). It is strongly inhibited by its product, G6P (allosteric feedback inhibition).
• Glucokinase (Hexokinase IV): Localized to hepatocytes and pancreatic $\beta$-cells. Has a high $K_m \approx 10\text{ mM}$ and displays positive cooperativity (sigmoidal saturation kinetics, Hill coefficient $n_H \approx 1.7$). It is not inhibited by physiological concentrations of G6P. Instead, it is regulated by binding to Glucokinase Regulatory Protein (GKRP), which sequesters it in the nucleus at low glucose and releases it into the cytosol when blood glucose rises following a carbohydrate meal. This allows the liver to rapidly clear high postprandial glucose surges.

Step 3: Phosphofructokinase-1 (PFK-1) — The Committed Pacemaker

PFK-1 catalyzes the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate (F-1,6-BP). This step represents the first committed step of carbohydrate catabolism (G6P can enter glycogen synthesis or the pentose phosphate pathway; F-1,6-BP has no other metabolic destination except glycolysis).

PFK-1 is a homotetramer ($M_r \approx 340\text{ kDa}$) possessing two distinct binding sites for ATP per subunit:

1. Catalytic Site: High affinity ($K_m$ for ATP is low, $\approx 0.02\text{ mM}$). ATP serves as the phosphoryl donor.
2. Allosteric Regulatory Site: Lower affinity for ATP. When intracellular ATP levels are elevated (indicating high energy charge), ATP binds to this inhibitory site, stabilizing the low-affinity T-state (Tense state) and shifting the substrate saturation curve for F6P to the right.

Allosteric Modulation of PFK-1:
  Active R-State  <===================>  Inactive T-State
  Stabilized by:                        Stabilized by:
   - Fructose-2,6-bisphosphate (potent)   - High [ATP]
   - AMP / ADP                            - Citrate (TCA saturation)
   - Pi                                   - H+ (acidosis / low pH)

• Citrate: Formed in the mitochondria during the first step of the TCA cycle, high cytosolic citrate signals that downstream oxidative pathways are saturated, synergistically reinforcing ATP inhibition of PFK-1.
• Protons ($\text{H}^+$): Lowering cytosolic pH (acidosis) inhibits PFK-1, a vital protective negative feedback mechanism that prevents excessive lactic acid accumulation during anaerobic exertion.
• AMP and Fructose-2,6-bisphosphate (F-2,6-BP): Bind to distinct allosteric activator sites, reversing ATP inhibition and stabilizing the high-affinity R-state (Relaxed state).

Step 6: Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH)

GAPDH couples the exergonic oxidation of the aldehyde carbon of GAP to an endergonic phosphorylation using inorganic phosphate ($\text{P}_i$), producing a mixed anhydride: 1,3-bisphosphoglycerate (1,3-BPG). The reaction proceeds through a covalent enzyme-substrate intermediate:

1. The active-site sulfhydryl group of Cysteine-149 ($-\text{SH}$) attacks the carbonyl carbon of GAP to form a tetrahedral hemithioacetal.
2. A hydride ion ($\text{H}:^-$) is transferred from the hemithioacetal to enzyme-bound $\text{NAD}^+$, forming a high-energy covalent thioester intermediate and $\text{NADH}$.
3. The reduced $\text{NADH}$ is displaced by a new $\text{NAD}^+$.
4. Inorganic phosphate ($\text{HPO}_4^{2-}$) attacks the thioester bond (phosphorolysis), releasing 1,3-BPG and regenerating the free Cys-149 thiolate.

PRC Board Exam Clinical & Toxicological Trap:

• Iodoacetate and Iodoacetamide: Alkylate the active-site Cys-149 sulfhydryl group (forming a stable $S$-carboxymethylcysteine derivative), irreversibly abolishing GAPDH activity and halting glycolysis.
• Arsenate ($\text{AsO}_4^{3-}$): Being structurally homologous to inorganic phosphate ($\text{P}_i$), arsenate substitutes for phosphate in the GAPDH reaction, generating 1-arseno-3-phosphoglycerate. This mixed anhydride is inherently unstable and undergoes instantaneous, non-enzymatic spontaneous hydrolysis to 3-phosphoglycerate and arsenate: $\text{1-Arseno-3-phosphoglycerate} + \text{H}_2\text{O} \longrightarrow \text{3-Phosphoglycerate} + \text{AsO}_4^{3-}$ As a consequence, 3-phosphoglycerate is formed without the generation of 1,3-BPG, completely bypassing Step 7 (Phosphoglycerate Kinase). Glycolysis continues, but the net ATP yield drops from $+2\text{ ATP}$ to $0\text{ ATP}$, depriving erythrocytes and anaerobic cells of energy!

Step 9: Enolase and Fluoride Inhibition

Enolase removes water from 2-phosphoglycerate (2-PG) to generate phosphoenolpyruvate (PEP). Although 2-PG is an ordinary alkyl phosphate ester with a standard free energy of hydrolysis ($\Delta G^{\circ\prime} \approx -17.6\text{ kJ/mol}$), enolase-catalyzed dehydration introduces a strained enol phosphate bond with an exceptionally high phosphoryl transfer potential ($\Delta G^{\circ\prime} = -61.9\text{ kJ/mol}$).

Enolase requires two divalent magnesium ions ($\text{Mg}^{2+}$) for catalytic activity. Fluoride ion ($\text{F}^-$), in the presence of inorganic phosphate, forms a stable magnesium fluorophosphate complex ($[\text{Mg}^{2+}\text{F}^-\text{PO}_4^{3-}]$) that coordinates irreversibly into the active site, inactivating enolase.

• In clinical laboratories, blood samples drawn for serum glucose determination are collected in gray-top tubes containing sodium fluoride (NaF) and potassium oxalate to inhibit erythrocyte enolase, preventing in vitro glycolytic consumption of glucose before analysis.

Step 10: Pyruvate Kinase — Energetics of Substrate-Level Phosphorylation

Pyruvate kinase transfers the phosphoryl group from PEP to ADP to form ATP and pyruvate. The reaction is driven by an enormous standard free energy change ($\Delta G^{\circ\prime} = -31.4\text{ kJ/mol}$):

$\text{PEP} + \text{ADP} \xrightarrow{\text{Pyruvate Kinase}} \text{Enolpyruvate} + \text{ATP} \quad (\Delta G^{\circ\prime} \approx -15\text{ kJ/mol})$ $\text{Enolpyruvate} \rightleftharpoons \text{Ketopyruvate} \quad (\Delta G^{\circ\prime} \approx -46\text{ kJ/mol})$

The instantaneous, spontaneous keto-enol tautomerization of the unstable enolpyruvate intermediate to ketopyruvate acts as a thermodynamic sink that pulls the phosphoryl transfer irreversibly forward.

---

Substrate-Level Phosphorylation vs. Oxidative Phosphorylation

---

Anaerobic Fates of Pyruvate: Fermentative NAD+ Regeneration

Under aerobic conditions, the electrons carried by cytosolic $\text{NADH}$ generated in Step 6 (GAPDH) are transferred into the mitochondrial electron transport chain via the malate-aspartate or glycerol-3-phosphate shuttle. Under hypoxic conditions or in cells lacking mitochondria (such as mature mammalian erythrocytes), $\text{NADH}$ cannot be oxidized by the ETC. Because cellular $\text{NAD}^+$ pools are small (sub-millimolar to about millimolar) relative to glycolytic flux, glycolysis would quickly halt as GAPDH runs out of $\text{NAD}^+$.

Fermentations solve this dilemma through redox-neutral processes:

Redox Coupling of Anaerobic Glycolysis:
  GAP + NAD+ + Pi  ======(GAPDH)======>  1,3-BPG + NADH + H+
         ^                                         |
         |                                         |
         +=========== (LDH) =======================+
                 Pyruvate + NADH + H+  <===>  Lactate + NAD+

1. Homolactic Fermentation

In vigorously exercising skeletal muscle, erythrocytes, and lactic acid bacteria, lactate dehydrogenase (LDH) reduces pyruvate to $\text{L-lactate}$ using $\text{NADH}$:

$\text{Pyruvate} + \text{NADH} + \text{H}^+ \xrightleftharpoons{\text{LDH}} \text{L-Lactate} + \text{NAD}^+ \quad (\Delta G^{\circ\prime} = -25.1\text{ kJ/mol})$

The equilibrium lies heavily toward lactate formation. When lactate accumulates in muscle, it diffuses into the bloodstream and is cleared by the liver via the Cori cycle.

2. Alcoholic Fermentation

In yeast (Saccharomyces cerevisiae) and other brewing microorganisms, pyruvate is converted to ethanol and $\text{CO}_2$ in a two-step sequence:

1. Pyruvate Decarboxylase: Pyruvate undergoes irreversible decarboxylation to acetaldehyde, releasing $\text{CO}_2$. The enzyme requires thiamine pyrophosphate (TPP) and $\text{Mg}^{2+}$ as cofactors: $\text{Pyruvate} \xrightarrow{\text{TPP, } \text{Mg}^{2+}} \text{Acetaldehyde} + \text{CO}_2$
2. Alcohol Dehydrogenase: Acetaldehyde is reduced to ethanol, with concomitant oxidation of $\text{NADH}$ to $\text{NAD}^+$: $\text{Acetaldehyde} + \text{NADH} + \text{H}^+ \xrightleftharpoons{\text{Zn}^{2+}} \text{Ethanol} + \text{NAD}^+$

Humans lack pyruvate decarboxylase and cannot produce ethanol endogenously from pyruvate.

---

Gluconeogenesis: The Anabolic Counter-Pathway

Gluconeogenesis is the synthesis of $\text{D-glucose}$ from non-carbohydrate precursors (pyruvate, lactate, glycerol, propionate, and all amino acids except leucine and lysine). In humans, approximately $90\%$ of gluconeogenesis occurs in the liver, with the remaining $10\%$ occurring in the renal cortex (which increases during prolonged metabolic acidosis or starvation).

Gluconeogenesis is not a simple reversal of glycolysis. While seven reversible glycolytic enzymes are shared, the three irreversible thermodynamic steps of glycolysis ($\Delta G \ll 0$) are bypassed by four distinct, exergonic enzymes:

Glycolysis Checkpoints vs. Gluconeogenic Bypasses:
  [Glucose] <============================================= [Glucose]
      | (Hexokinase / ATP)                     (G6Pase / H2O) ^
      v                                                       |
  [G6P]                                                     [G6P]
      |                                                       ^
      v                                                       |
  [F6P] <================================================= [F6P]
      | (PFK-1 / ATP)                        (FBPase-1 / H2O) ^
      v                                                       |
  [F-1,6-BP]                                             [F-1,6-BP]
      |                                                       ^
      v (Seven shared reversible reactions)                   |
  [PEP] <================================================= [PEP]
      | (Pyruvate Kinase)                      (PEPCK / GTP)  ^
      v                                                       |
  [Pyruvate] =====(Pyruvate Carboxylase / ATP)=====> [Oxaloacetate]

Bypass 1: Pyruvate to Phosphoenolpyruvate (Two Enzymatic Steps)

Because the pyruvate kinase reaction has a standard free energy of $-31.4\text{ kJ/mol}$, direct phosphorylation of pyruvate by ATP is thermodynamically impossible in cells. The bypass requires two steps and compartmental cooperation between the mitochondrial matrix and cytosol:

1. Pyruvate Carboxylase (Mitochondrial Matrix): Pyruvate is transported into the mitochondrial matrix, where pyruvate carboxylase carboxylates it to oxaloacetate (OAA): $\text{Pyruvate} + \text{HCO}_3^- + \text{ATP} \xrightarrow{\text{Biotin, } \text{Mg}^{2+}} \text{Oxaloacetate} + \text{ADP} + \text{P}_i$

   • Pyruvate carboxylase contains a covalently bound biotin prosthetic group linked to the $\varepsilon$-amino group of a lysine residue (forming a flexible biocytin arm). Biotin carries activated $\text{CO}_2$ (carboxybiotin).
   • The enzyme has an absolute requirement for acetyl-CoA as an obligate allosteric activator. When acetyl-CoA accumulates (indicating fatty acid breakdown and sufficient energy), it signals that oxaloacetate is needed for gluconeogenesis.

2. The Malate Shuttle (Transport of OAA Across the Mitochondrial Membrane): The inner mitochondrial membrane lacks a specific transporter for oxaloacetate. Therefore, mitochondrial malate dehydrogenase reduces OAA to L-malate using $\text{NADH}$: $\text{Oxaloacetate} + \text{NADH} + \text{H}^+ \rightleftharpoons \text{L-Malate} + \text{NAD}^+$ Malate is exported to the cytosol via the dicarboxylate antiporter and re-oxidized back to oxaloacetate by cytosolic malate dehydrogenase, transferring reducing equivalents ($\text{NADH}$) into the cytosol where they are needed for gluconeogenesis (Step 6 reversal).

3. Phosphoenolpyruvate Carboxykinase (PEPCK, Cytosolic): Oxaloacetate is decarboxylated and phosphorylated by PEPCK, using GTP as the phosphoryl donor: $\text{Oxaloacetate} + \text{GTP} \xrightarrow{\text{Mg}^{2+}} \text{PEP} + \text{GDP} + \text{CO}_2$ The decarboxylation of OAA releases $\text{CO}_2$ (the same carbon introduced by pyruvate carboxylase), providing the thermodynamic driving force to form the high-energy enol phosphate bond.

Bypass 2: Fructose-1,6-Bisphosphate to Fructose-6-Phosphate

Catalyzed by Fructose-1,6-bisphosphatase-1 (FBPase-1):

$\text{F-1,6-BP} + \text{H}_2\text{O} \xrightarrow{\text{Mg}^{2+}} \text{Fructose-6-P} + \text{P}_i \quad (\Delta G^{\circ\prime} = -16.3\text{ kJ/mol})$

This is a simple hydrolytic removal of the C1 phosphate group. It does not regenerate ATP.

Bypass 3: Glucose-6-Phosphate to Free Glucose

Catalyzed by Glucose-6-phosphatase:

$\text{Glucose-6-P} + \text{H}_2\text{O} \longrightarrow \text{D-Glucose} + \text{P}_i \quad (\Delta G^{\circ\prime} = -13.8\text{ kJ/mol})$

• Subcellular Localization: Glucose-6-phosphatase is an integral membrane protein anchored in the endoplasmic reticulum (ER) membrane of hepatocytes and renal cortex cells, with its catalytic active site oriented toward the ER lumen.
• Physiological Importance: Muscle tissue completely lacks glucose-6-phosphatase. Muscle cells can break down glycogen to G6P, but they cannot dephosphorylate G6P to export free glucose into the blood. Glycogen stored in muscle is committed exclusively to intracellular glycolysis for muscular work.

Stoichiometric Energetic Cost of Gluconeogenesis

Synthesizing one molecule of glucose from two molecules of pyruvate requires the input of six high-energy nucleoside triphosphate bonds:

$2\text{Pyruvate} + 4\text{ATP} + 2\text{GTP} + 2\text{NADH} + 2\text{H}^+ + 4\text{H}_2\text{O} \longrightarrow \text{Glucose} + 4\text{ADP} + 2\text{GDP} + 6\text{P}_i + 2\text{NAD}^+$

$\Delta G^{\circ\prime} = -16\text{ kJ/mol}$

Notice that if gluconeogenesis were merely the direct reversal of glycolysis, it would consume only $2\text{ ATP}$. The extra input of $4\text{ ATP/GTP}$ equivalents is the thermodynamic price required to make gluconeogenesis irreversible in the biosynthetic direction.

---

Reciprocal Regulation and the PFK-2/FBPase-2 Master Switch

To prevent a futile cycle (simultaneous high flux through both opposing pathways dissipating ATP as heat), glycolysis and gluconeogenesis are reciprocally regulated. When one is active, the other is suppressed.

The Bifunctional Enzyme: PFK-2/FBPase-2

Fructose-2,6-bisphosphate (F-2,6-BP) is not a metabolic intermediate in glycolysis or gluconeogenesis; it is purely a potent allosteric regulatory hormone-responsive signal. It is synthesized and degraded by a single, homodimeric bifunctional enzyme carrying two distinct catalytic domains on each polypeptide chain: phosphofructokinase-2 (PFK-2) and fructose-2,6-bisphosphatase-2 (FBPase-2).

Hormonal Regulation of the PFK-2 / FBPase-2 Switch in Liver:

 Glucagon (Fasting)                                Insulin (Fed State)
       |                                                   |
   GPCR Activation                                    Tyrosine Kinase
       |                                                   |
 [Adenylate Cyclase]                              [Phosphoprotein Phosphatase 1]
       |                                                   |
  cAMP Rises                                         Dephosphorylation
       |                                                   |
  PKA Activated                                            v
       |                                           [PFK-2 Active] / [FBPase-2 Inactive]
       v                                                   |
 Phosphorylation of Ser-32                                 v
       |                                            [F-2,6-BP Rises]
       v                                                   |
 [PFK-2 Inactive] / [FBPase-2 Active]                      v
       |                                          PFK-1 Stimulated / FBPase-1 Inhibited
       v                                                   |
  [F-2,6-BP Drops]                                         v
       |                                              GLYCOLYSIS ACTIVE
       v
 FBPase-1 Activated / PFK-1 Suppressed
       |
       v
 GLUCONEOGENESIS ACTIVE

• Fasting State (Glucagon): Glucagon binds to hepatic G-protein-coupled receptors, stimulating adenylate cyclase to produce cyclic AMP (cAMP). High cAMP activates Protein Kinase A (PKA). PKA phosphorylates a specific serine residue (Ser-32) on the regulatory domain of the bifunctional enzyme. Phosphorylation inactivates the PFK-2 domain and activates the FBPase-2 domain. As a result, cellular $[\text{F-2,6-BP}]$ plummets. In the absence of F-2,6-BP, PFK-1 is inhibited while FBPase-1 is relieved of inhibition, driving gluconeogenesis and hepatic glucose export.
• Fed State (Insulin): Following a meal, elevated insulin activates phosphoprotein phosphatase 1 (PP1). PP1 dephosphorylates the bifunctional enzyme. Dephosphorylation activates the PFK-2 domain and inactivates the FBPase-2 domain. $[\text{F-2,6-BP}]$ rises sharply, potently stimulating PFK-1 and shutting down FBPase-1, activating glycolysis.

The Cori Cycle (Lactic Acid Cycle)

Under strenuous muscular contraction, skeletal muscle ferments glucose to lactate via anaerobic glycolysis, gaining $2\text{ ATP}$ per glucose. Lactate is released into the blood and taken up by the liver. In hepatocytes, lactate is re-oxidized to pyruvate by LDH and converted back into glucose via gluconeogenesis, costing $6\text{ ATP/GTP}$. The synthesized glucose is released into the bloodstream and returns to muscle. The net cost of the cycle to the organism is $4\text{ ATP}$ equivalents ($6\text{ consumed in liver} - 2\text{ produced in muscle} = 4\text{ net cost}$), which prevents muscular acidosis and preserves functional capacity.

---

Glycogen Metabolism: Glycogenesis and Glycogenolysis

Glycogen is a highly branched homopolysaccharide of $\text{D-glucose}$ stored primarily in the liver (up to $10\%$ of liver wet weight; maintains blood glucose homeostasis) and skeletal muscle ($1-2\%$ of muscle weight; provides instant ATP for contraction).

• Primary Structure: Glucose units are linked by $\alpha(1\rightarrow 4)$ glycosidic bonds, with branches formed by $\alpha(1\rightarrow 6)$ glycosidic bonds occurring every $8-12$ glucose residues.

Glycogenesis (Glycogen Synthesis)

1. Phosphoglucomutase: Converts G6P to glucose-1-phosphate (G1P) via a glucose-1,6-bisphosphate intermediate.
2. UDP-Glucose Pyrophosphorylase: Activates G1P by reaction with UTP to form uridine diphosphate glucose (UDP-glucose): $\text{G1P} + \text{UTP} \xrightleftharpoons{\text{PPiase}} \text{UDP-glucose} + 2\text{P}_i$ The reaction is driven forward by the immediate hydrolysis of inorganic pyrophosphate ($\text{PP}_i$) by inorganic pyrophosphatase ($\Delta G^{\circ\prime} \approx -19\text{ kJ/mol}$).
3. Glycogenin Priming: Glycogen synthase cannot initiate chain synthesis de novo from free glucose. The protein glycogenin acts as an autolytic glucosyltransferase that attaches the first $8$ glucose units to its own Tyr-194 residue using UDP-glucose.
4. Glycogen Synthase: Elongates the polymer by transferring glucosyl residues from UDP-glucose to the non-reducing end of an existing chain, forming $\alpha(1\rightarrow 4)$ glycosidic bonds.
5. Branching Enzyme (Amylo-$(1,4\rightarrow 1,6)$-transglycosylase): Cleaves an internal block of $6-7$ residues from a chain at least $11$ residues long and reattaches it to a C6 hydroxyl group on an adjacent chain, forming a new $\alpha(1\rightarrow 6)$ branch point.

Glycogenolysis (Glycogen Breakdown)

1. Glycogen Phosphorylase: Catalyzes the phosphorolytic cleavage (phosphorolysis) of $\alpha(1\rightarrow 4)$ bonds from the non-reducing ends using inorganic phosphate ($\text{P}_i$): $\text{Glycogen}_{(n\text{ residues})} + \text{P}_i \xrightarrow{\text{PLP}} \text{Glycogen}_{(n-1\text{ residues})} + \text{Glucose-1-P}$
   • Requires pyridoxal 5'-phosphate (PLP), derived from Vitamin $B_6$, as an obligate prosthetic group.
   • Energetic Advantage: Because cleavage uses $\text{P}_i$ instead of water, the resulting glucose-1-phosphate is already phosphorylated without spending an ATP molecule!
   • Limit Dextrin: Glycogen phosphorylase cannot cleave $\alpha(1\rightarrow 4)$ bonds closer than four residues from an $\alpha(1\rightarrow 6)$ branch point. The branched structure halted at this point is called a limit dextrin.
2. Debranching Enzyme (Bifunctional Single Polypeptide):
   • $4\text{-}\alpha\text{-D-Glucanotransferase Activity:}$ Shifts a block of three glucosyl residues from the four-residue branch to a nearby non-reducing end, attaching them via an $\alpha(1\rightarrow 4)$ bond.
   • Amylo-$\alpha(1\rightarrow 6)$-Glucosidase Activity: Hydrolytically cleaves the single remaining glucose residue at the branch point, releasing free, unphosphorylated D-glucose.
   • Consequently, glycogen breakdown produces approximately $90\%$ glucose-1-phosphate and $10\%$ free glucose.

Hormonal Control of Glycogen Metabolism

Cascade Control of Glycogen Breakdown:
 Epinephrine / Glucagon  -->  cAMP Rises  -->  PKA Active
       |
       +--> Phosphorylates Phosphorylase Kinase (Inactive b --> Active a)
       |          |
       |          +--> Phosphorylates Glycogen Phosphorylase (Inactive b --> Active a)
       |                     | (Drives Glycogenolysis)
       |                     v
       |               Glycogen --> G1P
       |
       +--> Phosphorylates Glycogen Synthase (Active a --> Inactive b)
              (Halts Glycogenesis)

• Glucagon (liver) and Epinephrine (muscle/liver): Activate PKA. PKA phosphorylates and activates phosphorylase kinase, which in turn phosphorylates glycogen phosphorylase ($b \rightarrow a$), activating glycogenolysis. Simultaneously, PKA phosphorylates glycogen synthase ($a \rightarrow b$), turning off glycogenesis.
• Insulin: Activates Protein Phosphatase 1 (PP1). PP1 dephosphorylates both enzymes, converting glycogen phosphorylase to its inactive $b$ form and glycogen synthase to its active $a$ form, driving glycogen storage.

---

The Pentose Phosphate Pathway (Hexose Monophosphate Shunt)

The pentose phosphate pathway occurs in the cytosol and serves two primary biological functions:

1. Generation of reducing equivalents in the form of $\text{NADPH}$ for reductive biosynthetic reactions (fatty acid, cholesterol, and steroid hormone synthesis) and for maintaining cellular antioxidant defenses.
2. Production of ribose-5-phosphate for the synthesis of purine and pyrimidine nucleotides and coenzymes ($\text{NAD}^+$, $\text{NADP}^+$, $\text{FAD}$, $\text{CoA}$). No ATP is consumed or generated in this pathway.

1. The Oxidative Phase (Irreversible)

Three enzymatic reactions convert glucose-6-phosphate ($6\text{C}$) into ribulose-5-phosphate ($5\text{C}$), generating two molecules of $\text{NADPH}$ and one molecule of $\text{CO}_2$:

1. Glucose-6-Phosphate Dehydrogenase (G6PDH): $\text{G6P} + \text{NADP}^+ \rightleftharpoons \text{6-Phosphoglucono-}\delta\text{-lactone} + \text{NADPH} + \text{H}^+$ This is the rate-limiting, committed step of the PPP. It is strictly regulated by the availability of $\text{NADP}^+$ (allosteric feedback inhibition by $\text{NADPH}$).
2. Lactonase (6-Phosphogluconolactonase): $\text{6-Phosphoglucono-}\delta\text{-lactone} + \text{H}_2\text{O} \longrightarrow \text{6-Phosphogluconate} + \text{H}^+$
3. 6-Phosphogluconate Dehydrogenase: $\text{6-Phosphogluconate} + \text{NADP}^+ \longrightarrow \text{Ribulose-5-phosphate} + \text{NADPH} + \text{CO}_2$

$\text{Net Oxidative Phase: } \text{G6P} + 2\text{NADP}^+ + \text{H}_2\text{O} \longrightarrow \text{Ribulose-5-P} + 2\text{NADPH} + 2\text{H}^+ + \text{CO}_2$

2. The Non-Oxidative Phase (Reversible Interconversions)

When cells require more $\text{NADPH}$ than ribose-5-phosphate, ribulose-5-phosphate is converted into glycolytic intermediates (fructose-6-phosphate and glyceraldehyde-3-phosphate) through reversible carbon-shuffling reactions:

• Ribulose-5-Phosphate Isomerase: Converts ribulose-5-P to ribose-5-P.
• Ribulose-5-Phosphate 3-Epimerase: Converts ribulose-5-P to xylulose-5-P.
• Transketolase: Transfers a $2\text{-carbon}$ ketol group from a ketose donor to an aldose acceptor. Requires thiamine pyrophosphate (TPP) as a prosthetic group. $\text{Xylulose-5-P } (5\text{C}) + \text{Ribose-5-P } (5\text{C}) \xrightleftharpoons{\text{Transketolase}} \text{GAP } (3\text{C}) + \text{Sedoheptulose-7-P } (7\text{C})$
• Transaldolase: Transfers a $3\text{-carbon}$ dihydroxyacetone group from a ketose to an aldose via a covalent Schiff base intermediate with an active-site lysine residue. $\text{Sedoheptulose-7-P } (7\text{C}) + \text{GAP } (3\text{C}) \xrightleftharpoons{\text{Transaldolase}} \text{Fructose-6-P } (6\text{C}) + \text{Erythrose-4-P } (4\text{C})$
• Second Transketolase Reaction: $\text{Xylulose-5-P } (5\text{C}) + \text{Erythrose-4-P } (4\text{C}) \xrightleftharpoons{\text{Transketolase}} \text{Fructose-6-P } (6\text{C}) + \text{GAP } (3\text{C})$

$\text{Net Non-Oxidative Phase: } 3\text{ Pentose-P } (15\text{C}) \rightleftharpoons 2\text{ Hexose-P } (12\text{C}) + 1\text{ Triose-P } (3\text{C})$

G6PD Deficiency and Hemolytic Anemia

Glucose-6-phosphate dehydrogenase deficiency is the most common enzymatic disorder worldwide (affecting $>400$ million individuals; X-linked recessive).

In mature erythrocytes, the pentose phosphate pathway is the sole source of $\text{NADPH}$ because red blood cells lack mitochondria and the TCA cycle. $\text{NADPH}$ is essential to keep glutathione in its reduced state (GSH):

$\text{GSSG} + \text{NADPH} + \text{H}^+ \xrightarrow{\text{Glutathione Reductase (FAD)}} 2\text{ GSH} + \text{NADP}^+$ $\text{H}_2\text{O}_2 + 2\text{ GSH} \xrightarrow{\text{Glutathione Peroxidase (Selenium)}} \text{GSSG} + 2\text{H}_2\text{O}$

When G6PD-deficient patients are exposed to oxidative stressors (such as the antimalarial drug primaquine, sulfa antibiotics, naphthalene mothballs, or ingestion of fava beans containing divicine and isouramil—termed favism):

1. Erythrocytes cannot generate sufficient $\text{NADPH}$ to regenerate GSH.
2. Hydrogen peroxide and organic peroxides oxidize hemoglobin sulfhydryl groups, causing hemoglobin to precipitate into insoluble aggregates visible inside red cells as Heinz bodies.
3. Peroxides cause lipid peroxidation of red cell membranes, leading to acute intravascular and extravascular hemolytic anemia.